 |
|
Sentinel Node Biopsy for High-Risk Nonmelanoma Cutaneous Malignancy
Jeffrey D. Wagner, MD;
David Z. Evdokimow, MD;
Edward Weisberger;
David Moore, MD;
Tsu-Yi Chuang, MD, MPH;
Stacie Wenck, RNP;
John J. Coleman III, MD
Arch Dermatol. 2004;140:75-79.
Objective To evaluate the feasibility of sentinel node staging for detection of occult regional lymph node metastasis in high-risk cutaneous nonmelanoma malignancies.
Design Consecutive clinical case series.
Setting Referral university medical center.
Patients A consecutive sample of patients with a variety of high-risk nonmelanoma cutaneous malignancies without evidence of regional lymph node metastases.
Intervention Sentinel node biopsies were performed using preoperative lymphoscintigraphy, blue dye, and intraoperative radiolocalization.
Main Outcome Measure Sensitivity, determined by comparing the results of biopsy specimen evaluation with those of completion lymphadenectomy and/or clinical follow-up.
Results Twenty-four patients underwent sentinel node biopsy for the staging of 29 nodal basins identified by lymphoscintigraphy. Primary diagnoses were squamous cell carcinoma (n = 17), Merkel cell carcinoma (n = 5), and adenocarcinoma (n = 2). Seven patients (29%) had a tumor-positive sentinel node. Sentinel node biopsy followed by complete lymphadenectomy was performed in 12 patients and sentinel node biopsy alone in 12 patients. Tumor-positive lymph nodes were noted in 8 patients, 7 of whom also had positive sentinel nodes. There was 1 false-positive result (1/8 [12%]), in a patient with recurrent squamous cell carcinoma of the scalp. At a median follow-up of 10 months, no recurrences in a sentinel node–negative basin have been noted. Compared with all information, the sensitivity of sentinel node staging was 88% and the negative predictive value was 0.94.
Conclusions Sentinel node biopsy is a minimally invasive staging procedure useful in identifying occult regional lymph node disease in selected patients with nonmelanoma cutaneous malignancies. Further studies to verify these findings and develop formal guidelines are indicated.
From the Division of Plastic Surgery, Department of Surgery (Drs Wagner, Evdokimow, and Coleman, and Ms Wenck), and the Departments of Otolaryngology/Head and Neck Surgery (Mr Weisberger), Gynecology and Oncology (Dr Moore), and Dermatology (Dr Chuang), Indiana University School of Medicine, Indianapolis. The authors have no relevant financial interest in this article.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLES
Staging Workup, Sentinel Node Biopsy, and Follow-up Tests for Melanoma: Update of Current Concepts
Timothy M. Johnson, Carol R. Bradford, Stephen B. Gruber, Vernon K. Sondak, and Jennifer L. Schwartz
Arch Dermatol. 2004;140(1):107-113.
ABSTRACT
| FULL TEXT
Early Detection of Asymptomatic Pulmonary Melanoma Metastases by Routine Chest Radiographs Is Not Associated With Improved Survival
Hensin Tsao, Myra Feldman, Julie E. Fullerton, Arthur J. Sober, Daniel Rosenthal, and William Goggins
Arch Dermatol. 2004;140(1):67-70.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
Chen et al.
CA Cancer J Clin 2006;56:292-309.
ABSTRACT
| FULL TEXT
Invasive Squamous Cell Carcinoma of the Skin: Defining a High-Risk Group
Mullen et al.
Ann. Surg. Oncol. 2006;13:902-909.
ABSTRACT
| FULL TEXT
Web-only Content.
Arch Dermatol 2006;142:E1-E3.
FULL TEXT
Sentinel Lymph Node Biopsy for Evaluation and Treatment of Patients With Merkel Cell Carcinoma: The Dana-Farber Experience and Meta-analysis of the Literature.
Gupta et al.
Arch Dermatol 2006;142:685-690.
ABSTRACT
| FULL TEXT
Sentinel Lymph Node Biopsy in Recessive Dystrophic Epidermolysis Bullosa and Squamous Cell Carcinoma
Perez-Naranjo et al.
Arch Dermatol 2005;141:110-111.
FULL TEXT
Possible Role for Sentinal Node Biopsy in the Management of Squamous Cell Carcinomas in Inherited Epidermolysis Bullosa
Fine
Arch Dermatol 2004;140:1012-1013.
FULL TEXT
|
